Company Filing History:
11 out of 35 
9 out of 17,173 
2 out of 39 
Years Active: 2001-2019
Title: Innovations and Contributions of Jeffrey Lyle Gray
Introduction
Jeffrey Lyle Gray, based in Loveland, Ohio, is a prominent inventor known for his significant contributions to biotechnology and pharmaceutical research. With a remarkable portfolio of 23 patents, he has made strides in the field of human protein tyrosine phosphatase inhibitors that play crucial roles in regulating angiogenesis.
Latest Patents
Among his latest innovations, Gray has developed compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors. These compounds are pivotal in regulating angiogenesis, which is the process of forming new blood vessels. The patents detail not only the inhibitors but also the compositions and methods for utilizing these inventions to aid in therapeutic applications.
Career Highlights
Gray's career has included significant tenures at reputable companies such as Aerpio Therapeutics, Inc. and The Procter & Gamble Company. His work has centered around utilizing innovative approaches to solve complex biological problems, particularly those associated with vascular diseases.
Collaborations
Throughout his career, Gray has collaborated with notable colleagues, including Kande K D Amarasinghe and Cynthia Monesa Clark. These collaborations have contributed to advancing research and enhancing the effectiveness of his inventions within the scientific community.
Conclusion
Jeffrey Lyle Gray stands out as a visionary inventor in the biotechnology sector. His extensive work with protein inhibitors has the potential to transform therapeutic strategies for treating various diseases related to angiogenesis. Through his inventions, Gray continues to impact the field and inspire future innovations in medicine.